|
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Gut 2011;60:1269-1277 doi:10.1136/gut.2010.226225
Hepatology
Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy
Feng Liu1,
Li Chen1,2,
De-Min Yu1,
Lin Deng1,
Rong Chen1,
Yin Jiang3,
Liang Chen3,
Su-Yuan Huang1,
Jia-Lun Yu1,
Qi-Ming Gong1,
Xin-Xin Zhang1
+ Author Affiliations
1Department of Infectious Diseases, Institute of Infectious & Respiratory Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
2Deparment of Hepatology, Fuzhou Infectious Diseases Hospital, Fuzhou, China
3Shanghai Public Health Clinical Center, Shanghai, China
Correspondence to Professor Xin-Xin Zhang, Department of Infectious Diseases, Institute of Infectious & Respiratory Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Rd, Shanghai 200025, China; [email protected]
Revised 29 December 2010
Accepted 1 January 2011
Published Online First 2 February 2011
Abstract
Objective To investigate the evolution of hepatitis B virus (HBV) quasispecies (QS) within the reverse transcriptase (RT) region during the early stage of entecavir treatment and its impact on virological response, and to compare evolutionary patterns under different selective pressures.
Methods 31 patients with chronic hepatitis B receiving entecavir (17 responders and 14 partial responders according to the HBV DNA levels at week 48) and 25 patients receiving lamivudine (14 responders and 11 non-responders) as controls were included. An average of 26 clones (2892 total from both groups) spanning the RT region per sample was sequenced.
Results QS complexity and diversity, in addition to alanine aminotransferase and HBV DNA levels, were comparable between responders and partial responders at baseline. However, QS complexity in responders at week 4 was statistically lower than that in partial responders at the nucleotide level (0.6494 vs 0.7723, p=0.039). Net changes in diversity as well as the viral nucleotide substitution rate of responders were higher than those of partial responders, and both correlated with virological responses at both week 48 and the final visit (mean: 28 months). A preliminary model of QS evolution variables predicted 16 of 17 responders and 13 of 14 partial responders in the entecavir group. Despite significant differences between responders to entecavir and responders to lamivudine at week 4, the characteristics of QS were quite similar between partial responders to entecavir and non-responders to lamivudine.
Conclusions The evolutionary patterns of HBV RT QS differ between responders and partial responders during the early stage of entecavir treatment. Characteristics of HBV QS evolution during the first 4 weeks contribute to the prediction of long-term virological responses. The similar patterns of HBV RT QS in partial responders and non-responders receiving different nucleoside analogues may imply a novel mechanism of drug resistance, which warrants further investigation.
|
|
发表于 2012-12-23 14:17
